Frank Ricotta

There is and there isn't.

I think that's one of the unique things we've done is we made that integration effort relatively easy by incorporating some of the new emerging standards in healthcare space like FHIR.

So we've cut it down from in my last iteration was 12 to 18 months, and we're down to less than 60 days now.

Yeah, it's a, it's really kind of twofold.

So it's a couple of the partners we, you know, we, we go out in terms of direct sell mode.

Um, and we do have, uh, we do have a bit of inside sales, uh, support as well.

And then, um, and then through partners through indirect.

So we're, we're co-selling in, um, in a couple, a couple areas as well.

Yeah.

I think it's right now it's, it's easy about 150 to 200 K and, and with the target to get that, get that down under 20.

Yep.

And it takes, it takes a while at this stage and we're, we're still small.

So we, we have to sell it.

We have to sell the big vision and then hopefully they'll buy into the current state of the solution and we can get there.

I have five core team members and then an extended team of about 12.

Oh, that's a, that's an awesome question.

You know, at this stage, at this stage, you know, we're betting, obviously betting on our ability to execute.

So we, we've run it pretty thin.

So we've been in, in the first six months, you know, looking at the bank account, we just had a few hundred dollars in there at one particular point in time.

Well, maybe after we go get some institutional capital, but no, at this stage, it's really just working to keep your head above water and cash flow and trying to invest the profits we are making back into key growth elements.